Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Objects To Proximity Of Ferrlecit Reminder And Unbranded Ads

This article was originally published in The Pink Sheet Daily

Executive Summary

A reminder ad for the iron therapy on the back cover of a journal and a "belly band" around the issue with similar presentation elements represent a full product ad, FDA's ad division says. Watson makes an unsubstantiated claim for "easy administration."

You may also be interested in...



Present Serious, Not Common, Risks First, FDA Tells Watson In Letter On Gelnique

"Restroom stall cling" for the urinary incontinence drug used at medical meeting gets notice of violation letter from DDMAC.

Pfizer Oncology Pipeline Shows Pivot To Targeted Therapies

Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel